SYMPA
25.8.2020 09:02:06 CEST | Business Wire | Pressemeddelelse
HR-teknologiselskabet Sympa offentliggjorde i dag, at de har godkendt en majoritetsinvestering fra Providence Strategic Growth (“PSG”). PSG er et datterselskab af Providence Equity Partners, en af verdens førende kapitalfonde med fokus på teknologiselskaber. Det nordiske investeringsselskab Alfvén & Didrikson, der investerede i Sympa i 2016, forbliver minoritetsejere sammen med Sympas stiftere. Edward Hughes, Aldo Mareuse og Tobias Richter fra PSG sidder nu i Sympas bestyrelse. Ingen finansielle detaljer er offentliggjorte.
Der er multimedier i denne pressemeddelelse. Se hele meddelelsen her: https://www.businesswire.com/news/home/20200825005033/da/
“Vi valgte Sympa som partner, fordi det er et veldrevet og spændende firma med stort potentiale, som er på forkant med udviklingen af europæiske HR-systemer” siger Edward Hughes, CEO hos PSG. “Markedet vokser hurtigt, og virksomheder efterspørger nu avancerede digitale HR-værktøjer, hvilket skaber interessante vækstmuligheder for Sympa. Vi ser frem til at samarbejde med Keijo og hans team for at nå virksomhedens fulde potentiale og fremskynde den internationale ekspansion.”
Sympa blev grundlagt i 2005 og er i dag en af Nordens førende og hurtigst voksende leverandører af cloud-baserede HR-løsninger. Selskabets mest populære produkt, Sympa HR, er en omfattende HR-løsning for digital håndtering af HR, som giver et tydeligt overblik over medarbejderdata og HR-processer. PSG’s investering vil understøtte Sympas næste vækstfase; produktudvikling og strategisk M&A for at fremme ekspansionen i hele Europe. Medstifter og CEO Keijo Karjalainen fortsætter med at stå i spidsen for både den daglige drift og Sympas team bestående af 140 medarbejdere, fordelt på 8 kontorer i 5 lande.
“Lige siden vi grundlagde Sympa, har vi været overbevist om, at der er et uudforsket behov for HR-systemer, der kan håndtere alle HR-processer og muliggøre datadrevet HR-arbejde. Vi har også identificeret en mangel på HR-systemer til mellemstore virksomheder med aktiviteter i flere forskellige lande og den kompleksitet, det medfører. Ved at imødekomme begge disse behov og samtidig sætte kunden først, har Sympa været i stand til at vokse hurtigt, og med PSG på vores side, mener vi, at der er meget gode vilkår for at få en markedsledende position uden for vores nordiske hjemmemarkeder. Det bliver meget spændende at se, hvad fremtiden har at vise” siger Keijo Karjalainen, medstifter og CEO.
Sympa hjælper i øjeblikket mere end 700 virksomheder verden over med at fremme udviklingen af deres medarbejdere, strømline HR-processerne og træffe endnu smartere strategiske beslutninger. Sympas kunder inkluderer flere kendte brands som Dustin, LandboNord, WhiteAway, VMS Group og Napatech. Sympa har tidligere toppet IT-magasinet Red Heerings liste med de 100 mest lovende start-ups.
Om Sympa
Sympa HR er en komplet HR-løsning, der nemt kan tilpasses, så den matcher virksomheden perfekt, og brugerne kan fokuserer på medarbejderne og smart beslutningstagning. HR-løsningen giver et tydeligt og samlet overblik over alle medarbejderdata, hjælper med at automatisere en lang række af de daglige HR-opgaver og samler alle HR-data et sikkert sted. Sympa HR anvendes nu gennemsnitligt 650.000 gange hver måned i 700+ virksomheder i mere end 100 lande. I 2019 vandt Sympa ”Året HR-systemprojekt ”, og har en de højeste kundetilfredshedsrater inden for HR-teknologi i Europa. Læs mere om Sympa HR-løsningen og selskabet kunder på sympa.dk .
Om Providence Strategic Growth
PSG, et datterselskab af Providence Equity Partners (“Providence”), blev etableret i 2014 og fokuserer på kapitalinvesteringer i teknologiselskaber med stærk vækst. Providence er et førende kapitalforvaltningsselskab, der har en sektorfokuseret investeringsstrategi. Siden selskabets start i 1989 har Providence investeret i mere end 200 virksomheder og er en af de førende kapitalfonde med fokus på medier, kommunikation, uddannelse, software og serviceindustrien. Providence har tidligere investeret i TDC. Selskabet har hovedsæde i Boston, USA, og kontorer i London og Kansas City. Læs mere på https://www.provequity.com .
Om Alfvén & Didrikson
Det svenske investeringsselskab Alfvén & Didrikson er et veletableret selskab, som specialiserer sig i passionerede start-ups med internationale vækstambitioner. Siden 2010 har Alfvén & Didrikson investeret i hurtigt voksende nordeuropæiske virksomheder, som eksempelvis Quinyx, Trustly, Mentimeter, Acast, Offerta og PE Accounting. Læs mere på www.alfvendidrikson.com .
Se kildeudgaven på businesswire.com: https://www.businesswire.com/news/home/20200825005033/da/
Link:
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
JTB to Acquire Asian DMC Leader EXO Travel for Accelerated Global Growth18.6.2026 04:00:00 CEST | Press release
— Advancing JTB's “Departing Globally, Arriving Globally” Vision — JTB Corp. today announced that it has reached an agreement to acquire all the shares of All Wise Holdings Pte. Ltd., the operator of Bangkok-based EXO Travel Group, a leading Destination Management Companies (DMCs) in Asia. The acquisition will be made through a JTB group company in the Asia-Pacific region. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260615106801/en/ EXO Travel operates in the B2B market, primarily across Asia Pacific. For over 30 years, it has consistently maintained high customer satisfaction based on trust, achievements and high-quality service. The company has a strong brand presence in the affluent markets of Europe, North America and Australia, where the trust of partner companies contributes significantly to its value. Additionally, EXO Travel leverages its extensive network of destinations in Asia Pacific to develop strong products
LabGenius Therapeutics and LG Chem Enter a Research Collaboration, Option and License Agreement to Develop an AI/ML-Designed Tumour-Targeting Antibody18.6.2026 01:01:00 CEST | Press release
The companies have entered into a multi-year research collaboration, option and licensing agreement in which LabGenius Therapeutics will leverage its AI/ML-driven antibody discovery platform,EVA™, to design and engineer next-generation multispecifics with enhanced therapeutic properties LabGenius Therapeutics will receive an undisclosed upfront payment and potential early milestones, plus, if the option is exercised, potential triple-digit million clinical, regulatory, and commercial milestones, along with royalties on net sales LabGenius Therapeutics (“LabGenius”), a drug discovery company combining machine learning (ML) and high-throughput experimentation to optimise therapeutic antibodies, today announced a multi-year research collaboration, option and licensing agreement with LG Chem. The collaboration aims to identify next-generation multispecific antibodies designed to overcome the key limitations of existing immunotherapies, including on-target, off-tumour toxicities. Together,
Joe Vernachio Named President of SOREL18.6.2026 00:00:00 CEST | Press release
Columbia Sportswear Company (Nasdaq: COLM), a leading innovator in active outdoor apparel, footwear, accessories and equipment, today announced that Joe Vernachio will be the next President of SOREL. Founded in 1962, SOREL is a leader in functional and lifestyle footwear that can be worn anywhere from the tundra to the streets of New York City. “We’re excited to welcome Joe Vernachio back to the Columbia Sportswear family,” said Tim Boyle, CEO and Chair of the Board. “Joe is a terrific leader who can build on the great work, talent and momentum in place at SOREL.” Mr. Vernachio led the Mountain Hardwear brand for several years, until he left to become the COO and ultimately, the CEO of Allbirds. His background also includes time as Global Vice President for Product and Operations at The North Face, and key roles at Nike, Spyder, Roots, Calvin Klein and Patagonia. “Joe is a consumer‑focused, collaborative leader with a deep passion for product and brand storytelling. His energy, experti
Venture Global and EnBW Announce New LNG Purchase Agreements17.6.2026 22:30:00 CEST | Press release
Today, Venture Global, Inc. (NYSE: VG) and EnBW announced the execution of new, binding agreements for the purchase of approximately 0.82 million tonnes per annum (MTPA) of U.S. liquefied natural gas (LNG) from Venture Global for approximately five years commencing in 2026, to be supplied from Venture Global’s portfolio. The new agreements add to the existing long-term sales and purchase agreements (SPAs) between Venture Global and EnBW for 2 MTPA for 20 years. “As one of Germany’s top LNG suppliers, Venture Global is proud to strengthen our partnership with EnBW and support the region’s energy security with a reliable supply of LNG,” said Venture Global CEO Mike Sabel. “The new mid-term agreements build on our strong, long-standing relationship with EnBW and reflects our commitment to meeting our customers’ evolving energy needs. Our dynamic marketing platform uniquely positions us to provide supply solutions across the short, medium, and long term.” About Venture Global Venture Globa
Kinaxis Announces Results of Voting at Annual and Special Meeting of Shareholders17.6.2026 22:05:00 CEST | Press release
Kinaxis® Inc. (“Kinaxis” or the “Company”) (TSX:KXS), a global leader in end-to-end supply chain planning and orchestration, received approval for all resolutions put forward to shareholders at today’s Annual and Special Meeting of Shareholders (the “Meeting”), as detailed in the Company’s management information circular dated May 5, 2026 (the “Circular”). 1. Election of Directors Shareholders voted to elect all eight directors nominated to the Kinaxis board, to hold office until the close of the next annual meeting of shareholders of the Company or until their successors are elected or appointed. Name of Nominee Total Number of Votes For Percentage of Votes For Total Number of Votes Against Percentage of Votes Against Razat Gaurav 21,870,163 99.01% 219,468 0.99% Robert Courteau 20,882,945 94.54% 1,206,685 5.46% Gillian (Jill) Denham 21,474,486 97.22% 615,143 2.78% José Alberto Duarte 21,699,181 98.23% 390,448 1.77% Lynn Loewen 21,952,244 99.38% 137,387 0.62% Angel Mendez 21,410,402 96
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum
